[Oral benfotiamine therapy. Thus you protect the nerves of diabetic patients].
D000284:Administration, Oral; D018849:Controlled Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003929:Diabetic Neuropathies / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D004359:Drug Therapy, Combination; D006801:Humans; D010919:Placebos; D011355:Prodrugs / Q000008:administration & dosage*; D011736:Pyridoxine / Q000008:administration & dosage / Q000627:therapeutic use; D013831:Thiamine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D013997:Time Factors; D014805:Vitamin B 12 / Q000008:administration & dosage / Q000627:therapeutic use; D025101:Vitamin B 6 / Q000008:administration & dosage / Q000627:therapeutic use
D010919:Placebos; D011355:Prodrugs; D025101:Vitamin B 6; D011736:Pyridoxine; D014805:Vitamin B 12; D013831:Thiamine; C013835:benphothiamine